SIDE-OUT FOUNDATION
11208 Waple Mill Road, Fairfax, VA 22030 side-out.org

Total Revenue
$1,396,295
Total Expenses
$1,507,039
Net Assets
$2,690,179

Organizations Filed Purposes: The Side-Out Foundation was established to educate, empower, and unite the volleyball community through outreach, and drive change in the way that breast cancer is treated by owning and managing its very own game-changing stage IV breast cancer clinical trial, The Side-Out Protocol.Making breast cancer a manageable disease (such as diabetes) takes an organization with extraordinary vision & cutting-edge tactics. Established in 2004 by Richard Dunetz, The Side-Out Foundation and its team is dedicated to extending the lives of those living with stage IV breast cancer through game-changing research while educating students, volleyball teams and communities around the country about the importance of philanthropy and how it can be used to change the world. Since inception, The foundation has forged (I) groundbreaking collaborations with prestigious research teams, hospitals and research centers nationwide; (II) leveraged new technologies to amplify patient success in our clinical trial and;

The Foundation was established to educate, empower, and unite the volleyball community to outreach to others, and drive change in the way that breast cancer is treated by owning and managing its very own stage IV breast cancer clinical trial The Side-Out Protocol.

Fundraisers nationwide including Dig Pink volleyball events were held in support of Side-Outs breast cancer research. Funds raised were used for advancing the effective approach to the treatment of stage IV breast cancer. During the Fiscal Year 2020, the foundation concluded the enrollment of the latest Side-Out sponsored trial, a nationwide effort to help doctors understand and predict response to treatment in newly diagnosed metastatic breast cancer patients. This trial was conducted at 8 treatment centers across the country where individuals received treatment consisting of 1 of the 3 latest drugs utilizing multi-omic advanced diagnostics to identify CDK4/6 inhibitor response predictors and a post-treatment multi-omic signature for patients with ER+/HER2-metastatic breast cancer. Additionally, in 2020 the foundation launched a 50 patient pilot focused on getting 10 years of Side-Outs clinical research in the hands of patients nationwide through a personalized report utilizing our multi-omic precision medicine approach.

Executives Listed on Filing

Total Salary includes financial earnings, benefits, and all related organization earnings listed on tax filing

NameTitleHours Per WeekTotal Salary
Rick DunetzExecutive Dir.40$85,423
Charlene CariouDirector5$0
Sinjin SmithDirector5$0
Dr Cecile ReynaudDirector5$0
Richard AlderDirector5$0
Bryant DunetzCOO/SECRETARY15$0

Data for this page was sourced from XML published by IRS (public 990 form dataset) from: https://s3.amazonaws.com/irs-form-990/202110379349300606_public.xml